Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

Hexcel Corporation

HXL

NEUTRAL

May 30, 2026

Research Conclusion

At $91, HXL is a Neutral/Hold for new capital. The irreplaceable aerospace-composites moat and multi-decade recovery thesis remain intact, but the stock has already re-rated from ~$62 (mid-2024) to $91 ahead of an earnings recovery pushed out 2-3 years. Base DCF intrinsic value is ~$76 with a range of $64–$96. For investors owning from lower entry points, hold; for new positions, wait for a pullback to $70-80 range.

Company Overview & Moat Assessment

Hexcel Corporation is a global advanced-composites manufacturer producing carbon fiber, prepregs, woven reinforcements, and engineered honeycomb core for commercial aerospace (~60% of revenue—Airbus A350, Boeing 787, A220, A320neo), space & defense (~20%—F-35, CH-53K, satellites, hypersonics), and industrial markets (~20%—wind turbine blades). Headquartered in Stamford, CT with major manufacturing in Salt Lake City, Spain, France, and the UK, Hexcel is the #1 or #2 supplier of qualified aerospace prepregs globally. FY2025 revenue was $1.89B, essentially flat YoY due to A350 customer destocking, with adjusted EPS of $1.76.

▲ Bull Case

  • ◆Operating leverage realization at $2.5B+ revenue: Returning to FY2019 revenue level with post-COVID cost discipline should drive EBIT margin from 18% toward 21-23% by FY2028-2030, implying EPS path to $5-6.
  • ◆Buyback acceleration already validated: Diluted shares dropped from 81.7M (FY2023) to 75.4M (Q1 2026), a 7.7% reduction; with FCF ramping to $300M+ by FY2028, sustained $200M/year buybacks could compound EPS gains.
  • ◆Quality moat with 17+ year tail: Once qualified on a program, switching costs are prohibitive (5-10 year re-qual, $50-200M); Hexcel's positions on the 787 and A350 are effectively monopoly supplier roles for the remaining 20-30 year program lives.

▼ Bear Case

  • ◆Multiple already prices in successful recovery: At $91, forward P/E is ~40x on FY2026E EPS and ~28x on FY2027E, well above peer median (~20x); risk/reward is fair-to-modest-upside in base, with -23 to -34% downside in bear scenario.
  • ◆Boeing 787 execution remains structurally constrained: 787 production has not exceeded 5-6/month for 4+ years despite multiple targets; the FY2027 path to 7/month depends on Boeing's quality system rebuild and IAM labor stability—both unproven.
  • ◆Variant case already disproven: Prior bull thesis assumed margins and revenue would be in recovery; reality (FY2025 EPS $1.76, decline YoY) shows the operating leverage thesis is delayed; the lever exists but takes 2-3 more years than previously modeled.
Primary Debate on Wall Street

“Two camps: Bulls (BofA, Morgan Stanley equivalents) with 1-year PT ~$90-100 argue Q1 2026's +18.8% commercial aero growth is the real inflection; FY2027 EPS of $3+ justifies $90+ stock. Skeptics (Jefferies) cut PT to $80 on valuation grounds, viewing FY2027 EPS consensus of $3.26 as aggressive and arguing the 28x FY27 multiple is too rich for an industrial-cyclical name with Boeing concentration risk. Consensus median PT of $86.44 sits between, implying the market is roughly balanced but slightly bearish vs. current price.”

Top Catalysts
  • ◆A350 production rate confirmation toward 9/mo by year-end 2026 (+$5-10/share if confirmed)
  • ◆Boeing 787 monthly rate exceeding 6/mo on sustained basis, H2 2026-2027 (+$8-12/share if structural)
  • ◆Buyback acceleration announcement (>$200M annual) in FY2027 earnings (+$3-5/share)
  • ◆FY2027 guidance issued at >$2.4B revenue in Q4 2026 earnings (+$5-8/share)
  • ◆NGAD or hypersonic program award in FY2026-2027 (+$3-5/share)
Top Risks
  • ◆A350 destock recurrence in FY2027 could compress valuation by -$10-15/share if sustained
  • ◆Boeing IAM/labor disruption blocks 787 rate ramp in FY2026-2027 (-$8-12/share)
  • ◆Multiple compression from rising rates or sector de-rating (-$10-15/share)
  • ◆European energy cost re-escalation in FY2026-2027 (-$5-8/share margin compression)
  • ◆Thermoplastic composite adoption on next-gen narrowbody in 2030s (long-term thesis risk)

Full Memo Continues

5 more sections, locked

  • ●
    Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • ●
    Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • ●
    Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • ●
    Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • ●
    Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/HXL/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.

Hexcel Corporation (HXL) — Investment Memo | Margin of Insight